SE9702799D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9702799D0 SE9702799D0 SE9702799A SE9702799A SE9702799D0 SE 9702799 D0 SE9702799 D0 SE 9702799D0 SE 9702799 A SE9702799 A SE 9702799A SE 9702799 A SE9702799 A SE 9702799A SE 9702799 D0 SE9702799 D0 SE 9702799D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- cycloalkyl
- enantiomers
- alkoxy
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (40)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702799A SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | New compounds |
TW087111330A TW438781B (en) | 1997-07-25 | 1998-07-13 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
DK98934104T DK1000048T3 (da) | 1997-07-25 | 1998-07-15 | Substituerede 1,2,3,4-tetrahydronapthalenderivater |
CN98809246A CN1270585A (zh) | 1997-07-25 | 1998-07-15 | 取代的1,2,3,4-四氢化萘衍生物 |
PL98338563A PL338563A1 (en) | 1997-07-25 | 1998-07-15 | Substituted derivatives of 1,2,3,4-tetrahydronaphtalene |
EP98934104A EP1000048B1 (fr) | 1997-07-25 | 1998-07-15 | Derives de 1,2,3,4-tetrahydronaphthalene substitue |
NZ502384A NZ502384A (en) | 1997-07-25 | 1998-07-15 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives as serotonin receptor antagonists |
KR1020007000743A KR20010022171A (ko) | 1997-07-25 | 1998-07-15 | 치환된 1,2,3,4-테트라히드로나프탈렌 유도체 |
YU2300A YU2300A (sh) | 1997-07-25 | 1998-07-15 | Derivati supstituisanog 1,2,3,4-tetrahidronaftalina |
AU83703/98A AU739569B2 (en) | 1997-07-25 | 1998-07-15 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
RU2000104802/04A RU2194696C2 (ru) | 1997-07-25 | 1998-07-15 | Производные 1,2,3,4-тетрагидронафталина, способы их получения, фармацевтическая композиция на их основе и способ лечения |
DE69809755T DE69809755T2 (de) | 1997-07-25 | 1998-07-15 | Substituierte 1,2,3,4-tetrahydronaphthalin derivate |
SI9830343T SI1000048T1 (en) | 1997-07-25 | 1998-07-15 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
UA2000021064A UA69389C2 (uk) | 1997-07-25 | 1998-07-15 | Заміщені похідні 1,2,3,4-тетрагідронафталіну, спосіб їх одержання, фармацевтична композиція та проміжні продукти для їх одержання |
BR9811042-0A BR9811042A (pt) | 1997-07-25 | 1998-07-15 | Composto, formulação farmacêutica, uso de um composto, e, processos para o tratamento de distúrbios no sistema nervoso central e/ou de incontinência urinária, vasoespasmos e controle do crescimento de tumores e para a preparação do composto |
ES98934104T ES2187983T3 (es) | 1997-07-25 | 1998-07-15 | Derivados 1,2,3,4-tetrahidronaftaleno sustituidos. |
PCT/SE1998/001390 WO1999005134A1 (fr) | 1997-07-25 | 1998-07-15 | Derives de 1,2,3,4-tetrahydronaphthalene substitue |
IL13410898A IL134108A0 (en) | 1997-07-25 | 1998-07-15 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
CA002296518A CA2296518A1 (fr) | 1997-07-25 | 1998-07-15 | Derives de 1,2,3,4-tetrahydronaphthalene substitue |
SK1883-99A SK283918B6 (sk) | 1997-07-25 | 1998-07-15 | Substituované deriváty 1,2,3,4-tetrahydronaftalénu, spôsob ich prípravy, medziprodukty na ich prípravu, farmaceutické prípravky s ich obsahom a ich použitie |
PT98934104T PT1000048E (pt) | 1997-07-25 | 1998-07-15 | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno |
EEP200000041A EE04238B1 (et) | 1997-07-25 | 1998-07-15 | Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid, meetod selle valmistamiseks, nimetatud terapeutilise toimega aineid sisaldavad ravimkoostised ja nimetatud aktiivsete ühendite kasutamine teraapias |
IDW20000122A ID24583A (id) | 1997-07-25 | 1998-07-15 | Turunan-turunan 1,2,3,4-tetrahidronaftalena tersubstitusi |
US09/171,577 US6313118B1 (en) | 1997-07-25 | 1998-07-15 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
TR2000/00229T TR200000229T2 (tr) | 1997-07-25 | 1998-07-15 | İkame edilmiş 1,2,3,4-Tetrahidronaftalen türevle i |
AT98934104T ATE228510T1 (de) | 1997-07-25 | 1998-07-15 | Substituierte 1,2,3,4-tetrahydronaphthalin derivate |
MA25169A MA26521A1 (fr) | 1997-07-25 | 1998-07-15 | Derives de 1,2,3,4-tetrahydronaphthalene substitue. |
HU0004334A HUP0004334A3 (en) | 1997-07-25 | 1998-07-15 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for producing them and pharmaceutical compositions containing them |
JP2000504131A JP3895923B2 (ja) | 1997-07-25 | 1998-07-15 | 置換された1,2,3,4−テトラヒドロナフタレン誘導体 |
DZ980179A DZ2569A1 (fr) | 1997-07-25 | 1998-07-22 | Dérivés 1,2,3,4-tétrahydronaphtalène substitués. |
TNTNSN98141A TNSN98141A1 (fr) | 1997-07-25 | 1998-07-23 | Derives 1,2,3, 4-tetrahydronapthalene substitues |
HR980404A HRP980404B1 (en) | 1997-07-25 | 1998-07-23 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
ZA986588A ZA986588B (en) | 1997-07-25 | 1998-07-23 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
ARP980103667A AR013370A1 (es) | 1997-07-25 | 1998-07-24 | Derivados de 1,2,3,4-tetrahidronaftaleno sustituidos, formulacion farmaceutica que los comprende, su uso en la manufactura de un medicamento,proceso para su preparacion y compuestos intermediarios |
IS5358A IS5358A (is) | 1997-07-25 | 2000-01-24 | Útskiptar 1,2,3,4-tetrahýdrónaftalen afleiður |
NO20000356A NO315609B1 (no) | 1997-07-25 | 2000-01-24 | Substituerte 1,2,3,4-tetrahydronaftalenderivater, farmasöytisk formuleringinneholdende slike, fremgangsmåte for deres fremstilling, oganvendelse derav |
HK00105178A HK1025963A1 (en) | 1997-07-25 | 2000-08-17 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
US09/902,123 US6534652B2 (en) | 1997-07-25 | 2001-07-10 | Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives |
US09/902,000 US6410532B2 (en) | 1997-07-25 | 2001-07-10 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
ARP040103875A AR046193A2 (es) | 1997-07-25 | 2004-10-25 | Derivados de piperidil o piperazinil 1,2,3,4-tetrahidronaftaleno sustituido, formulacion farmaceutica, usos en la manufactura de medicamentos, y proceso para su preparacion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702799A SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9702799D0 true SE9702799D0 (sv) | 1997-07-25 |
Family
ID=20407828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9702799A SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | New compounds |
Country Status (37)
Country | Link |
---|---|
US (3) | US6313118B1 (fr) |
EP (1) | EP1000048B1 (fr) |
JP (1) | JP3895923B2 (fr) |
KR (1) | KR20010022171A (fr) |
CN (1) | CN1270585A (fr) |
AR (2) | AR013370A1 (fr) |
AT (1) | ATE228510T1 (fr) |
AU (1) | AU739569B2 (fr) |
BR (1) | BR9811042A (fr) |
CA (1) | CA2296518A1 (fr) |
DE (1) | DE69809755T2 (fr) |
DK (1) | DK1000048T3 (fr) |
DZ (1) | DZ2569A1 (fr) |
EE (1) | EE04238B1 (fr) |
ES (1) | ES2187983T3 (fr) |
HK (1) | HK1025963A1 (fr) |
HR (1) | HRP980404B1 (fr) |
HU (1) | HUP0004334A3 (fr) |
ID (1) | ID24583A (fr) |
IL (1) | IL134108A0 (fr) |
IS (1) | IS5358A (fr) |
MA (1) | MA26521A1 (fr) |
NO (1) | NO315609B1 (fr) |
NZ (1) | NZ502384A (fr) |
PL (1) | PL338563A1 (fr) |
PT (1) | PT1000048E (fr) |
RU (1) | RU2194696C2 (fr) |
SE (1) | SE9702799D0 (fr) |
SI (1) | SI1000048T1 (fr) |
SK (1) | SK283918B6 (fr) |
TN (1) | TNSN98141A1 (fr) |
TR (1) | TR200000229T2 (fr) |
TW (1) | TW438781B (fr) |
UA (1) | UA69389C2 (fr) |
WO (1) | WO1999005134A1 (fr) |
YU (1) | YU2300A (fr) |
ZA (1) | ZA986588B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
SE9900190D0 (sv) * | 1999-01-22 | 1999-01-22 | Astra Ab | New compounds |
SE9904724D0 (sv) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
SE0002729D0 (sv) * | 2000-07-20 | 2000-07-20 | Astrazeneca Ab | Novel compound form |
AR034206A1 (es) * | 2001-02-16 | 2004-02-04 | Solvay Pharm Bv | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos |
SE0102856D0 (sv) * | 2001-08-27 | 2001-08-27 | Astrazeneca Ab | A new method |
SE0103644D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic isoquinoline compounds |
US7101881B2 (en) * | 2003-06-11 | 2006-09-05 | Pfizer Inc | Tetrahydroquinolines |
SE0301798D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use IV |
SE0301794D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use III |
WO2005113527A1 (fr) * | 2004-05-21 | 2005-12-01 | Pfizer Products Inc. | Tetrahydronaphthylpiper- azines utilisees en tant qu'agonistes inverses, agonistes partiels et antagonistes de 5-ht1b |
US20080033050A1 (en) * | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
WO2008130323A1 (fr) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Nouveaux dérivés 8-pipérazine-tétrahydronaphtalène utilisés pour le traitement de la douleur |
WO2008130319A2 (fr) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Nouveaux composés 805 |
WO2008130322A1 (fr) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Nouveaux dérivés 5-hétérocyclyl-chromane utilisés pour le traitement de la douleur |
WO2008130321A2 (fr) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Nouveaux composés 807 |
SA08290245B1 (ar) * | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم |
EP2098511A1 (fr) | 2008-03-07 | 2009-09-09 | Solvias AG | Procédé pour la préparation de composés contenant une structure d'hydronaphtalène avec un cycle benzène à substitution asymétrique |
ME01516B (me) | 2008-06-20 | 2014-04-20 | Astrazeneca Ab | DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA |
GB201002563D0 (en) | 2010-02-15 | 2010-03-31 | Cambridge Entpr Ltd | Compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
CA2914263C (fr) | 2013-06-21 | 2021-05-18 | Takeda Pharmaceutical Company Limited | Derives de 1-sulfonyl piperidine utilises en tant que modulateurs des recepteurs de la prokineticine |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3919624A1 (de) | 1989-06-15 | 1990-12-20 | Boehringer Ingelheim Kg | Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
GB9119920D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
EP0533268B1 (fr) | 1991-09-18 | 2001-08-16 | Glaxo Group Limited | Dérivés de benzanilide comme 5-HT1D antagonistes |
GB9119932D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
DK148392D0 (da) | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
GB2273930A (en) | 1992-12-30 | 1994-07-06 | Glaxo Group Ltd | Benzanilide derivatives |
AU6391894A (en) * | 1993-03-16 | 1994-10-11 | Pfizer Inc. | Naphthalene derivatives |
WO1995011243A1 (fr) | 1993-10-19 | 1995-04-27 | Smithkline Beecham Plc | Derives de benzanilide en tant qu'antagonistes du recepteur de 5ht-1d |
SE9601110D0 (sv) | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
-
1997
- 1997-07-25 SE SE9702799A patent/SE9702799D0/xx unknown
-
1998
- 1998-07-13 TW TW087111330A patent/TW438781B/zh not_active IP Right Cessation
- 1998-07-15 CA CA002296518A patent/CA2296518A1/fr not_active Abandoned
- 1998-07-15 ID IDW20000122A patent/ID24583A/id unknown
- 1998-07-15 DK DK98934104T patent/DK1000048T3/da active
- 1998-07-15 TR TR2000/00229T patent/TR200000229T2/xx unknown
- 1998-07-15 MA MA25169A patent/MA26521A1/fr unknown
- 1998-07-15 SK SK1883-99A patent/SK283918B6/sk unknown
- 1998-07-15 SI SI9830343T patent/SI1000048T1/xx unknown
- 1998-07-15 NZ NZ502384A patent/NZ502384A/en unknown
- 1998-07-15 DE DE69809755T patent/DE69809755T2/de not_active Expired - Fee Related
- 1998-07-15 YU YU2300A patent/YU2300A/sh unknown
- 1998-07-15 CN CN98809246A patent/CN1270585A/zh active Pending
- 1998-07-15 EP EP98934104A patent/EP1000048B1/fr not_active Expired - Lifetime
- 1998-07-15 BR BR9811042-0A patent/BR9811042A/pt not_active IP Right Cessation
- 1998-07-15 IL IL13410898A patent/IL134108A0/xx unknown
- 1998-07-15 EE EEP200000041A patent/EE04238B1/xx not_active IP Right Cessation
- 1998-07-15 AU AU83703/98A patent/AU739569B2/en not_active Ceased
- 1998-07-15 PL PL98338563A patent/PL338563A1/xx unknown
- 1998-07-15 US US09/171,577 patent/US6313118B1/en not_active Expired - Fee Related
- 1998-07-15 UA UA2000021064A patent/UA69389C2/uk unknown
- 1998-07-15 JP JP2000504131A patent/JP3895923B2/ja not_active Expired - Fee Related
- 1998-07-15 ES ES98934104T patent/ES2187983T3/es not_active Expired - Lifetime
- 1998-07-15 KR KR1020007000743A patent/KR20010022171A/ko not_active Application Discontinuation
- 1998-07-15 PT PT98934104T patent/PT1000048E/pt unknown
- 1998-07-15 RU RU2000104802/04A patent/RU2194696C2/ru not_active IP Right Cessation
- 1998-07-15 AT AT98934104T patent/ATE228510T1/de not_active IP Right Cessation
- 1998-07-15 WO PCT/SE1998/001390 patent/WO1999005134A1/fr not_active Application Discontinuation
- 1998-07-15 HU HU0004334A patent/HUP0004334A3/hu unknown
- 1998-07-22 DZ DZ980179A patent/DZ2569A1/fr active
- 1998-07-23 TN TNTNSN98141A patent/TNSN98141A1/fr unknown
- 1998-07-23 ZA ZA986588A patent/ZA986588B/xx unknown
- 1998-07-23 HR HR980404A patent/HRP980404B1/xx not_active IP Right Cessation
- 1998-07-24 AR ARP980103667A patent/AR013370A1/es unknown
-
2000
- 2000-01-24 NO NO20000356A patent/NO315609B1/no not_active IP Right Cessation
- 2000-01-24 IS IS5358A patent/IS5358A/is unknown
- 2000-08-17 HK HK00105178A patent/HK1025963A1/xx not_active IP Right Cessation
-
2001
- 2001-07-10 US US09/902,123 patent/US6534652B2/en not_active Expired - Fee Related
- 2001-07-10 US US09/902,000 patent/US6410532B2/en not_active Expired - Fee Related
-
2004
- 2004-10-25 AR ARP040103875A patent/AR046193A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9702799D0 (sv) | New compounds | |
SE9703378D0 (sv) | New compounds | |
SE9703377D0 (sv) | New compounds | |
NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
HUP0203228A2 (hu) | Szubsztituált indolszármazékok az NFKB-aktivitás módosítására, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE206611T1 (de) | Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung | |
HUP0302480A2 (hu) | Piridinonszármazékok ateroszklerózis kezelésére, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények | |
HUP0300565A2 (hu) | PDE 5 inhibitor hatású 8-kinolin-xantin- és 8-izo-kinolin-xantin-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AR035892A1 (es) | Derivados de oxazol, proceso para su preparacion, composiciones farmaceuticas que los comprenden, y el uso de dichos compuestos en la preparacion de medicamentos | |
SE0101579D0 (sv) | New compounds | |
DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
HUP0104058A2 (hu) | N-diszubsztituált piperazin vagy 1,4 diszubsztituált piperidin heterociklusos származékai és ezeket tartalmazó gyógyászati készítmények | |
HUP9903758A2 (hu) | Benzoxazinon dopamin D4 receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények | |
PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
CA2085796A1 (fr) | Derives 3(2h)-pyridazinone et procede pour leur preparation | |
HUP0002929A2 (hu) | Tachikinin receptor antagonista hatású 2-acilamino-propán-aminok és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0203187A2 (hu) | Izoxazolszármazékok mint foszfodiészteráz VII inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
DE69512208T2 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
HUP0201863A2 (hu) | Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
ATE268328T1 (de) | Neue diazol-derivate und ihre verwendung als serotonergische wirkstoffe | |
YU16196A (sh) | Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka | |
HUP0204149A2 (hu) | Új szulfoniloxazolamin-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására | |
NO20020475D0 (no) | 2-aminotetralinderivater for terapi av glaukom | |
ES2027492A6 (es) | Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables. | |
HUP0402388A2 (hu) | N-(indolkarbonil-)piperazin-származékok alkalmazása gyógyszerkészítmények előállítására |